Wealthcraft Capital Inc. (OTC PINK: WCCP) (“Wealthcraft” or the “Company”) is pleased to provide an update with respect to corporate strategy and recent acquisition initiatives.

With the passage of the 2018 Farm Bill, Wealthcraft is refocusing its acquisition strategy towards hemp cultivation, processing and Cannabidiol (“CBD”) products. “The 2018 Farm Bill changes the entire landscape for the production, marketing, distribution and sale of CBD and other health and wellness-oriented cannabinoids,” said Robert Wilson, President of Wealthcraft. “We believe that this new law will release restrictions in banking and capital markets and accelerate the growth by opening up all aspects of the CBD supply chain.”

Acquisition Update

In response to its focus on CBD, Wealthcraft is pleased to announce that it has entered into letters of intent to acquire a controlling interest in two CBD companies. The first company is a Pennsylvania-based chain of medical clinics that specialize in providing advice and certification for patients seeking cannabinoid-based therapy. Through their nine clinics, approximately 25 wholesale distributors and approximately 25,000 registered patients, the company provides medical cannabis certification services and sells CBD products both online and through their network of clinics.

“By leveraging the patient base of their partner-physicians, the company is able to directly reach a wide segment of the population who suffer from a variety of chronic illnesses,” said Robert Wilson, President of Wealthcraft. “We believe this is a unique and sustainable model for CBD sales, education and research that has incredible potential as the company undertakes its expansion into four additional states in 2019,” Wilson added.

The second letter of intent is with a Colorado-based company which produces and sells a variety of branded CBD products, including sublingual & topical sprays, gel caps, vape-pens, and a recently launched, proprietary metered CBD inhaler. The company has a strategic partnership with one of Colorado’s largest processing labs, which ensures a continuous supply of consistent quality, full spectrum CBD oil and isolate to meet current and future product demand.

“The team at Wealthcraft will be working closely with our Denver CBD partner to launch the new products, expand the company’s online reach and fulfill various wholesale channels with product inventory,” said Robert Wilson, President of Wealthcraft. “With the development and implementation of federal regulations in the CBD industry, we believe that having a well-funded, full scale supplier who is moving towards GMP compliance will be a critical competitive advantage.”

Separately, Wealthcraft recently terminated its negotiations that were announced on October 15, 2018, to acquire a controlling interest in a licensed cultivator of cannabis in Las Vegas, Nevada. Pursuant to the terms and conditions of the letter of intent, $100,000 of the deposit has been returned to Wealthcraft.

About Wealthcraft Capital

Wealthcraft Capital is a health and wellness company focused on acquiring private companies in the emerging hemp and CBD industry. The Company intends to acquire controlling interests in businesses with a view to becoming vertically integrated across hemp cultivation and processing, CBD-based product production, branding, distribution and sales. Wealthcraft intends to work with these acquisition partners to develop wholesale markets, products and brands that can be introduced into the retail wellness market as well as patient-based facilities and clinics.

This Press Release contains certain “forward-looking statements” as such term is defined in Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). These statements reflect our current expectations regarding our possible future results of operations, performance, and achievements. Wherever possible, the Company has tried to identify these forward-looking statements by using words such as “anticipate,” “believe,” “estimate,” “expect,” “plan,” “intend,” and similar expressions. These statements reflect our current beliefs and are based on information currently available to us. Accordingly, these statements are subject to certain risks, uncertainties, and contingencies, which could cause our actual results, performance, or achievements to differ materially from those expressed in, or implied by, such statements. Further, the safe harbor provisions of the Exchange Act may not apply to an issuer that issues penny stock. These statements speak only as of the date of this press release. Actual results may differ materially from those indicated by such forward- looking statements as a result of various important factors. The Company does not assume any obligation to update any forward-looking statements to reflect events or circumstances after the date of this Press Release except as required by applicable law.


Adam Sexton
O 310-564-1240

Source: www.businesswire.com

BevCanna Enterprises (CSE:BEV,OTCQQ:BVNNF,FWB:7BC) CEO Marcello Leone shared how the company is scaling up its products to forge partnerships and explore opportunities across Canada, the US and Western Europe. 

“Getting your standard processing license and being fully compliant at a federal level is critical in Canada, and we were successful in getting that done. Now we’re getting ready to launch our Keef line of beverages within the next 45 days,” Leone said. 

As a young company, Leone said BevCanna has only started, but it took a four-pronged approach to make sure that it is a revenue-generating company prepared for the opening of many jurisdictions for CBD-based products.

“We are blessed that we have a beautiful infrastructure of our own, a state-of-the-art bottling facility with a capacity of almost 200 million bottles per annum and a strong balance sheet of $55 million. We are in a strong position to scale and grow this company.”

BevCanna has received a Standard Processing License from Health Canada and is now fully authorized to begin production at its full-service, high-capacity beverage manufacturing facility. The company will begin production of its white-label products, number one US cannabis beverage brand Keef and its in-house beverages through licensed Canadian retailers, positioning the company to fully capitalize on the burgeoning Canadian cannabis-infused beverage sector.

Watch the full interview with CEO Marcello Leone above.

Keep reading... Show less

BioHarvest Sciences (CSE: BHSC) will be presenting at the Benzinga Cleantech Small Cap Conference taking place on April 22, 2021. We invite our shareholders and all interested parties to explore cleantech small cap investment opportunities through two days of networking, dealmaking and discovery.

Sign up to get a free spectator pass for the event: https://www.benzinga.com/events/small-cap/clean-tech/

Keep reading... Show less

Positive distributor feedback and strong consumer interest accelerating launch with distributors

Emerging leader in innovative health and wellness beverages and products, BevCanna Enterprises Inc. ( CSE:BEV , Q:BVNNF , FSE:7BC ) (“ BevCanna ” or the “ Company ”) announces today that its wholly-owned subsidiary Naturo Group has successfully completed its initial shipment of TRACE plant-based products to one of Japan’s largest beverage distributors.

Keep reading... Show less

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco Labs” or the “Company”), a vertically integrated multistate operator and the number one U.S. wholesaler of branded cannabis products, today announced an additional refreshment of its board of directors to further strengthen its leadership in the cannabis industry.

Keep reading... Show less